CD8A and neoplasm: Therefore, ACAT1-deficient CD8+T cells have been shown to enhance the function and proliferation of effector cells by accelerating immune synapse formation and improving TCR aggregation and signal transduction to increase the damage to tumor cells and improve the therapeutic effect of GC [168].